|
April 1989 |
NKK corp. (current JFE Steel Corporation) |
|
September 1994 |
Sumitomo Pharmaceuticals (current Sumitomo Pharma Co., Ltd) |
|
August 2001 |
Daiichi Pharmaceuticals Co., Ltd. (current Daiichi Sankyo Co., Ltd.) |
|
February 2009 |
Sumitomo Dainippon Pharma Co., Ltd (current Sumitomo Pharma Co., Ltd) Corporate Strategic Planning office |
|
Jun 2011 |
Global Oncology Office |
|
February 2013 |
Executive Director of Business Development in Boston Biomedical Inc(Cambridge, MA) |
|
January 2014 |
Director of Global Oncology Office |
|
April 2014 |
Deputy Executive Director of Drug Research Division, Director of Global Oncology Office |
|
December 2014 |
Deputy Executive Director of Drug Research Division, Director of External innovation and Development Office |
|
April 2016 |
Senior Director of Global Business Development |
|
April 2017 |
Executive Officer, Senior Director of Global Business Development, International Business Management |
|
April 2020 |
Senior Executive Officer, Global Corporate Strategy, Global Business Development, International Business Management |
|
Jun 2022 |
Board of Directors, Senior Executive Officer Global Business Development, International Business Management |
|
July 2024 |
Managing Executive Officer, Global Business Development |
|
August 2025 |
Marubeni Pharmaceuticals Corporation President and COO |